AMP vs APi Which Is Stronger?

AMP and API stocks are two popular investment opportunities within the financial sector. AMP Limited is a leading Australian wealth management company, specializing in superannuation, insurance, and banking services. On the other hand, Australian Pharmaceutical Industries (API) is a major player in the health and beauty retail sector, operating well-known brands such as Priceline Pharmacy. Investors often compare and contrast the performance of these two stocks to determine which may offer better returns and growth potential in their portfolios.

AMP or APi?

When comparing AMP and APi, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between AMP and APi.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. AMP has a dividend yield of 3.09%, while APi has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. AMP reports a 5-year dividend growth of 0.00% year and a payout ratio of 103.31%. On the other hand, APi reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with AMP P/E ratio at 33.02 and APi's P/E ratio at 51.83. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. AMP P/B ratio is 1.07 while APi's P/B ratio is 3.63.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, AMP has seen a 5-year revenue growth of -0.97%, while APi's is -0.08%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with AMP's ROE at 3.19% and APi's ROE at 7.58%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $0.66 for AMP and $38.37 for APi. Over the past year, AMP's prices ranged from $0.58 to $0.94, with a yearly change of 62.07%. APi's prices fluctuated between $30.26 and $40.89, with a yearly change of 35.13%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.